Publikationen 1993 - 1995

  1. Boos J, Hohenlochter B, Schulze-Westhoff P, Schiller M, Zimmermann M, Creutzig U, Ritter J, Jürgens H: Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia. Med Pediatr Oncol 1996;26:397-404. PM:8614376
  2. Boos J, Schiller M, Pröbsting B, Creutzig U, Ritter J: Intracellular retention of cytosine-arabinoside-triphosphate in leukemic blast cells from children. Haematol Blood Transf 1996;37:50-53.
  3. Creutzig U: Diagnosis and treatment of acute myelogenous leukemia in childhood. Crit Rev Oncol Hematol 1996;22:183-196.
  4. Creutzig U, Ritter J, Vormoor J, Ludwig WD, Niemeyer C, Reinisch I, Stollmann-Gibbels B, Zimmermann M, Harbott J: Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia 1996;10:1677-1686.
  5. Creutzig U, Schrappe M: [Acute leukemia in childhood. Classification--diagnosis--therapy-- prognosis]. Internist (Berl) 1996;37:982-993. PM:9019456
  6. Creutzig U, Ritter J, Zimmermann M, Klingebiel T: Prognose von Kindern mit chronischer myeloischer Leukämie: Eine retrospektive Analyse von 75 Patienten. Klin Pädiatr 1996;208:236-241.
  7. Creutzig U, Ritter J, Harbott J, Zimmermann M, Löffler H, Schwartz S, Lampert F: Biological entities in acute myelogenous leukemia according to morphological, cytogenetic and immunological criteria: Data of Study AML-BFM-87. Haematol Blood Transfus 1996;V:524-535.
  8. Creutzig U: Cancer in the children of survivors of acute leukemia or non- Hodgkin's lymphomas in childhood. Strahlenther Onkol 1996;172:690-691.
  9. Creutzig U, Ritter J, Zimmermann M, Klingebiel T: [Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients]. Klin Padiatr 1996;208:236-41. http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&u...
  10. Creutzig U, Ritter J, Harbott J, Zimmermann M, Löffler H, Schwartz S, Lampert F, Ludwig W-D: Biological entities in acute myelogenous leukemia according to morphological, cytogenetic and immunological criteria: Data of Study AML-BFM-87. Haematol Blood Transf 1996;37:524-535.
  11. Stahnke K, Ritter J, Boos J, Creutzig U: Mitoxantrone-etoposide or HD-Ara-C/mitoxantrone for remission induction in children with first relapse of AML. Haematol Blood Transf 1996;37:200-202.
  12. Suttorp M, Lion T, Creutzig U, Klingebiel T, Gadner H: Treatment of chronic myeloid leukemia in children and adolescents--concept of the multicenter pilot study CML-ped. Klin Pädiatr 1996;208:242-249.
  13. Vormoor J, Boos J, Stahnke K, Jurgens H, Ritter J, Creutzig U: Therapy of childhood acute myelogenous leukemias. Ann Hematol 1996;73:11-24. PM:8695718
  14. Creutzig U, Ritter J, Ludwig WD, Niemeyer C, Reinisch I, Stollmann-Gibbels B, Zimmermann M, Harbott J: [Acute myeloid leukemia in children with Down syndrome]. Klin Padiatr 1995;207:136-44. http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&u...
  15. Creutzig U, Graf N: Früherkennung von Neoplasien im Kindesalter. (Sonderheft Früherkennung). Onkologie 1995;18:24-27.
  16. Creutzig U, Sperling Ch, Harbott J, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig W-D: Clinical significance of surface antigen expression in children with acute myeloid leukemia: Results of Study AML-BFM-87. Blood 1995;86:3097-3108.
  17. Creutzig U, Ritter J, Ludwig WD, Niemeyer C, Reinisch I, Stollmann-Gibbels B, Zimmermann M, Harbott J: [Acute myeloid leukemia in children with Down syndrome]. Klin Padiatr 1995;207:136-144. PM:7564143
  18. Creutzig U: Therapie von Tumoren und malignen Systemerkrankungen des Kindes.; in Zeller WJ, zur Hausen H, (eds): Onkologie. Landsberg, Ecomed Verlagsgesellschaft, 1995.
  19. Klumper E, Pieters R, Kaspers GJL, Huismans DR, Loonen AH, Rottier MMA, van Wering ER, van der Does-van den Berg A, Hählen K, Creutzig U, Veerman AJP: In vitro chemosensitivity assessed with the MTT assay in childhood acute nonlymphoblastic leukemia. Leukemia 1995;9:1864-1869.
  20. Seyger MM, Ritterbach J, Creutzig U, Gnekow AK, Göbel U, Graf N, Reiter A, Lampert F, Harbott J: 12q13, a new recurrent breakpoint in acute non-lymphoblastic leukemia. Cancer Genet Cytogenet 1995;80:23-28.
  21. Sperling C, Büchner T, Creutzig U, Ritter J, Harbott J, Fonatsch C, Sauerland C, Mielcarek M, Löffler H, Ludwig WD: Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML. Leukemia and Lymphoma 1995;17:417-426.
  22. Creutzig U, Winkler K: Empfehlungen zur Optimierung von Therapieschemata. Klin Padiatr 1994;206:191-193. PM:7967415
  23. Creutzig U, Ritter J, Zimmermann M, Schellong G: Superior results by cranial irradiation in children with acute myelogenous leukemia: An update of study AML-BFM-87. Onkologie 1994;17:66-68.
  24. Cantú Rajnoldi A, Biondi A, Jankovic M, Masera G, Rovelli A, Uderzo C, Head D, Raimondi S, Creutzig U, Ritter J: Diagnosis and incidence of acute promyelocytic leukemia (FAB M3 and M3 variant) in childhood [letter]. Blood 1993;81:2209-2210.
  25. Creutzig U, Ritter J, Schellong G, for the AML-BFM Study Group: Cranial irradiation is essential in the treatment of childhood acute myelogenous leukemia: Results of Study AML-BFM-87. Haematol Blood Transf 1993;36:468-475.
  26. Creutzig U, Ritter J, Ludwig WD, Harbott J, Löffler H, Schellong G: Klassifikation der AML nach morphologischen, immunologischen und zytogenetischen Kriterien - Übersicht unter Berücksichtigung der Subtypen in der Studie AML-BFM-87. Klin Pädiatr 1993;205:272-280.
  27. Creutzig U, Ritter J, Zimmermann M, Schellong G: Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87. J Clin Oncol 1993;11:279-286. PM:8426205
  28. Stahnke K, Creutzig U, Ritter J, for the AML-BFM Study Group: Second remission in relapsed childhood acute myelogenous leukemia after pretreatment with the AML-BFM-83 protocol. Haematol Blood Transf 1993;36:500-504.
Suchen
Benutzeranmeldung